- Home
- LEGH vs LAB Comparison
LEGH vs LAB Comparison
Compare LEGH & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGH
- LAB
- Stock Information
- Founded
- LEGH 2005
- LAB 1999
- Country
- LEGH United States
- LAB United States
- Employees
- LEGH N/A
- LAB N/A
- Industry
- LEGH Homebuilding
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- LEGH Consumer Discretionary
- LAB Industrials
- Exchange
- LEGH Nasdaq
- LAB Nasdaq
- Market Cap
- LEGH 588.8M
- LAB 473.2M
- IPO Year
- LEGH 2018
- LAB 2011
- Fundamental
- Price
- LEGH $26.74
- LAB $1.23
- Analyst Decision
- LEGH Strong Buy
- LAB Buy
- Analyst Count
- LEGH 2
- LAB 2
- Target Price
- LEGH $29.00
- LAB $2.50
- AVG Volume (30 Days)
- LEGH 60.9K
- LAB 1.4M
- Earning Date
- LEGH 08-07-2025
- LAB 08-11-2025
- Dividend Yield
- LEGH N/A
- LAB N/A
- EPS Growth
- LEGH 2.38
- LAB N/A
- EPS
- LEGH 2.23
- LAB N/A
- Revenue
- LEGH $184,284,000.00
- LAB $172,271,000.00
- Revenue This Year
- LEGH N/A
- LAB N/A
- Revenue Next Year
- LEGH $7.69
- LAB $12.18
- P/E Ratio
- LEGH $12.01
- LAB N/A
- Revenue Growth
- LEGH 8.79
- LAB 26.39
- 52 Week Low
- LEGH $21.58
- LAB $0.92
- 52 Week High
- LEGH $29.25
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- LEGH 76.96
- LAB 43.04
- Support Level
- LEGH $24.50
- LAB $1.15
- Resistance Level
- LEGH $27.29
- LAB $1.37
- Average True Range (ATR)
- LEGH 1.06
- LAB 0.07
- MACD
- LEGH 0.44
- LAB -0.02
- Stochastic Oscillator
- LEGH 85.71
- LAB 26.67
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.